verified SJR 1,449 · Q1 • database Scopus / SJR & Web of Science indexed

United States · W.B. Saunders

workspace_premium Q1 — Hematology lock Subscription

Seminars in Hematology

Seminars in Hematology is a journal indexed in SJR in Hematology with an H index of 104. It has an SJR impact factor of 1,449 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,449.

ISSN: 0037-1963

Publisher: W.B. Saunders

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

1,449 Q1

H-index 104

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,449

H-index

104

Docs (year)

Docs 3y

110

Total refs

5867

Cites 3y

408

Citable 3y

Cites/Doc 2y

3.54

Ref/Doc

91.67

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cell function-based flow cytometry

Use of recombinant factor VIIa (NovoSeven[reg ]) in patients with Glanzmann thrombasthenia

Diagnostic advances in defining erythropoietic abnormalities and red blood cell diseases

Developmental therapeutics for multiple myeloma[mdash ]A road map for the future

Design of clinical trials to evaluate the efficacy of platelet transfusion: The trial for components treated with Helinx[trade ] technology

Current use and future development of gemtuzumab ozogamicin

Current status and perspectives of therapy for acute myeloid leukemia

Current issues with platelet transfusion in patients with cancer

Comparative genomic hybridization: Uses and limitations

Clinical management of [beta ]-thalassemia major

Clinical implications of recurring chromosomal and associated molecular abnormalities in acute lymphoblastic leukemia

Clinical experience with recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia

SHOW MORE ARTICLES

Chelation therapy in [beta ]-thalassemia: An optimistic update

Active site-inhibited seven: Mechanism of action including signal transduction

Cell culture and animal models to screen for promising fetal hemoglobin[mdash ]stimulating compounds

Can drugs cause autoimmune thrombocytopenic purpura?

Biologic and structural differences of thrombopoietic growth factors

Bacterial contamination of platelet concentrates: Incidence, significance, and prevention

Approach to the investigation and management of immune thrombocytopenic purpura in children

Aplastic Anemia: What Have We Learned From Animal Models and From the Clinic

Anticomplement Treatment in Atypical and Typical Hemolytic Uremic Syndrome

Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy

Allogeneic hematopoietic cell transplantation for multiple myeloma

Advances in the diagnosis of idiopathic thrombocytopenic purpura

FAQs

Seminars in Hematology has an SJR of 1,449 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Seminars in Hematology is 25%.

Seminars in Hematology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Seminars in Hematology?

What is the APC / publication cost?

What is the acceptance rate?